About
TargTex develops targeted localized therapies using selective small molecules as adjuncts to surgery for hard-to-treat central nervous system cancers, primarily focusing on glioblastoma.
Explore TargTex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.